Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ford Motor Company (F) vs Smith & Nephew plc (SNN) Price & Performance

Ford Motor CompanyTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Ford Motor Company vs Smith & Nephew plc — how do they compare? Ford Motor Company trades at $14.13 (market cap $56.50B), while Smith & Nephew plc trades at $31.37 (market cap $12.81B). The key difference: Ford Motor Company is far larger — about 4.4× Smith & Nephew plc's market cap, and Ford Motor Company pays the higher dividend (4.23%). Which is the better fit depends on your goals.

FSNN
Market Cap
$56.50B$12.81B
Sector
Consumer CyclicalHealth
52-Week High
$17.44$38.70
52-Week Low
$10.82$28.73
Enterprise Value
$185.53B$15.58B
Dividend Yield
4.23%2.54%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ford Motor Company

Ford (F) trades at $14.09, up 1.15% today, with a bullish technical signal from moving averages and a consensus analyst price target of $15.00. Recent earnings show volatility with Q1 2026 beating expectations but Q4 2025 missing, while revenue grew to $187.27 billion in 2025. The company maintains strong cash flow from operations at $21.28 billion and announced a $0.15 dividend for H1 2026, though net income was negative at -$8.18 billion due to high costs.

Ford's outlook is mixed, with opportunities from EV expansion and labor stability, but risks include profit margin pressure and rising debt. Analysts are cautiously optimistic with 34% buy ratings, yet investors should weigh competitive threats and macroeconomic headwinds against the stock's low P/E of 11.84 and dividend yield.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $31.41, up 5.28% today, with a bullish technical signal from moving averages. The company shows improving fundamentals with revenue growth from $5.8B in 2024 to $6.2B projected for 2025 and net income margin expanding to 10.14%. Recent product launches in robotics and wound care, plus a $500M share buyback, highlight strategic execution. Analyst consensus is mixed with 27% buy ratings but 68% hold, reflecting cautious optimism amid earnings volatility where two of the last four quarters missed expectations.

Outlook: SNN's recovery trajectory and product innovation support long-term growth, but investor patience is needed due to earnings inconsistency and moderate debt levels. Key risks include competitive pressures in medtech and execution on guidance. The stock presents a value opportunity if operational improvements continue, trading at reasonable valuations (P/E 21.5, P/S 2.18) versus sector peers.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ford Motor Company

Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.

Read more on F

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN